By maintaining and enhancing management efficiency, transparency and soundness, we strive to continuously create corporate value and make ourselves even more attractive to our shareholders.
Our most important challenges are to strengthen our R&D activities from a long-term perspective, increase our competitiveness by developing new businesses, and maintain long-term growth of our business performance.
We are also working hard to enhance corporate governance with the aim of developing a trusted and attractive corporate culture. Management transparency and soundness are being boosted, and management monitoring and oversight functions are being strengthened through the appointment of independent outside directors and auditors.
Code of Conduct to fulfill Responsibility to Shareholders
1. When evaluating business activities, we shall focus not only on final results but also on business processes that deliver those results. We will strive to accurately and explicitly record our business activities.
2. We shall disclose information on management and business activities in a timely and appropriate manner.
1. We shall not use, for our private interests, undisclosed material information which we have come to know through conducting our business and which concerns JSR Group and/or other companies in which we engage.
2. In the case that we have and hold any undisclosed material information, we shall not release such information until it is disclosed officially. Additionally, we shall not sell and/or purchase JSR's and/or other relevant companies' shares or relevant financial products until official disclosures are made.
JSR Group strives to promote investor relations (IR) with due consideration for our shareholders and investors, and to disseminate information regarding business situation and corporate policies promptly and accurately.
Panel exhibition at a shareholders' meeting
JSR has implemented a variety of measures to facilitate the exercise of shareholder voting rights. These include the holding of the general shareholders' annual meeting at an earlier date to avoid the typical peak period of shareholders' meetings, earlier notification for the meeting, the adoption of a voting system via Internet, participation in electronic platforms for the exercise of voting rights by institutional investors, and the listing of invitations to shareholders' meetings on our website in both Japanese and English.
We aim to make documents attached to invitations to our shareholders' meetings easy to understand. To this end, we provide not only legally required content, but also other useful information, such as information regarding our products and an overview of our mid-term business plan. Additionally, we make effective use of graphs, photographs, and color printing.
We also ensure that ordinary general meetings of shareholders are accessible and easy to understand for all shareholders by adopting various measures such as the exhibition of panels to explain about JSR, video and audio information relating to our business conditions, and the President's briefing on the mid-term business plan.
IR meetings
In addition to conducting briefings on our business results after each quarter, we also organize seminars for investment institutions and analysts as well as various other events to achieve extensive bi-directional communication with shareholders and investors.
In the FY2016, we held seven seminars for corporate investment analysts. We hold a total of nearly 250 meetings for investors in Japan and overseas per year. Feedback on opinions and questions received through these meetings is shared with management on a regular basis.
With regard to the global development of JSR Group companies, we intend to implement IFRS* from March 2018 in an effort to improve the comparability of financial information regarding international capital markets.
* International Financial Reporting Standards
We held a meeting for securities company analysts and members of the mass media to explain JSR Group's Life Sciences Business.
Along with the Life Sciences Division, we presented JSR Life Sciences Corporation, Medical & Biological Laboratories Co., Ltd., and KBI Biopharma, Inc., all of which are members of JSR Group, and the JSR-Keio University and Chemistry Innovation Center, which is a joint research facility to be created with Keio University's School of Medicine. We also presented the products they will produce.
Our website provides information regarding stock price, news, and other topics in a timely manner
In order to provide the latest information regarding our financial and business performances, JSR Group's website contains the section, "Investor Relations." This section includes the latest IR information, news releases, and the latest stock price information, which are indicated in a way that is easy to see. The section also presents various types of IR information, including documents regarding our business results, annual reports, IR news, information related to our stocks, documents regarding our shareholders' meetings, and our company information for individual investors. We strive to provide necessary information in a timely and easy-to-understand manner.
Annual Report 2017
We publish an annual report (available only in English) every year regarding the relevant fiscal year's financial results, and management and business situations.
JSR Throughout Society Part 9
We send the "JSR Throughout Society (available only in Japanese) " brochure to our shareholders. This brochure aims to help our shareholders to understand that our Group's products are used extensively for a wide range of materials and parts needed in society. The brochure explains how our products are utilized in leading-edge fields such as fuel-efficient tires, smart phones, and life sciences field.
* Shares owned by individual Japanese investors, etc. include treasury shares (1.57%).
The number of JSR shareholders was 16,586 as of March 31, 2017; shareholder composition is as follows: